Why the Zelira (ASX:ZLD) share price is storming 7% higher

The Zelira Therapeutics Ltd (ASX: ZLD) share price is firmly in the green today following a positive update for its HOPE products. Here’s the details.

| More on:
ASX Cannabis share price represented by asx investor holding card with cannabis leaf on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zelira Therapeutics Ltd (ASX: ZLD) share price is firmly in the green today following a positive update for its HOPE products.

At the time of writing, the cannabis company’s shares are swapping hands for 5.7 cents, up 7.55%.

What did Zelira announce?

Investors appear upbeat by the company’s latest announcement, sending the Zelira share price higher.

According to this morning’s release, Zelira advised its HOPE products have launched in Washington DC. Additionally, Zelira noted that this occurred through its partnership with Alternative Solutions. 

Alternative Solutions is a licenced grower, manufacturer, and distributor of medical cannabis products. The company operates in the District of Columbia (Washington DC), United States.

Furthermore, both companies entered into an exclusive licence agreement in late 2020 to expand the market presence for Zelira’s range of HOPE products.

Currently, Washington DC has an agreement with 32 other states within the country for approved medical cannabis programs. The mutual exchange allows patients who are registered in the authorised states to legally buy medical cannabis in Washington DC.

Zelira stated that HOPE is available at the National Holistic Healing Centre, located near Dupont Circle.

As part of the deal, Zelira will receive an upfront fee and ongoing royalties from product sales within Washington DC. The company did not provide any further details regarding the financial aspects of the contract.

In addition, Zelira holds a licencing agreement with Ilera Healthcare LLC and Advanced Biomedics LLC for Pennsylvania and Louisiana, respectively. Management believes that customer adoption and sales will be similar in Washington DC and other markets.

Management commentary

Zelira managing director, Dr Oludare Odumosu hailed the company’s success, saying:

The successful launch of HOPE in Washington DC is a huge step forward in Zelira’s strategic focus on expanding access to HOPE throughout the USA. We look forward to partnering with Alternative Solutions to support the growth of our product in these new markets.

Alternative Solutions CEO, Matt Lawson-Baker further commented:

We are thrilled to partner with Zelira in bringing HOPE to Washington DC and look forward to bringing patients scientifically formulated medicines they can trust.

Zelira share price snapshot

Since the beginning of 2021, investors have seen the Zelira share price continue to fall in value. Year-to-date performance stands at a loss of more than 40%, reflecting weak shareholder sentiment.

Based on current valuations, Zelira presides a market capitalisation of around $63 million, with close to 1.2 billion shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Share Gainers

Why is the Incannex share price spiking 8% on Tuesday?

The stock has caught a bid on Tuesday.

Read more »

Researcher putting cannabis leaf in test tube.
Share Fallers

The Incannex share price has plunged 70% so far in 2022. What’s gone so wrong?

Downside continues over the past month for the cannabis stock.

Read more »

The sunset silhouette of a person leaping in the air as a large bird flies over head.
Cannabis Shares

Off and racing: Zelira shares fly 37% higher on Thursday

The stock has gained a whopping 111% so far this week.

Read more »

A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
Cannabis Shares

Why is the Althea share price up 20% in 4 days?

This nano-cap ASX cannabis share has caught the attention of investors this week.

Read more »

An older farmer wearing a checkered shirt and a straw hat stands in a green field of cannabis plants growing up to waist level as he smiles while thinking about the outlook for ASX cannabis shares in FY23
Cannabis Shares

Green shoots or just weeds? The outlook for ASX cannabis shares in FY23

Are cannabis stocks set to rise along with the broader industry in the new financial year?

Read more »

A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
Cannabis Shares

How did ASX cannabis shares perform in FY22?

Here's a look at the sector's performance in the financial year just gone.

Read more »

little green pharma share price represented by cannabis leaf character jumping cheerfully
Cannabis Shares

Little Pharma shares lift 8% amid appointment of ‘highly regarded’ director

Little Green Pharma shares are smoking the market today.

Read more »

Rising cannabis share price.
Cannabis Shares

Why is the Cann share price smoking out the ASX by 20% today

Cann shares are in the green on Thursday.

Read more »